Subsidiary of China Meheco Group (600056.SH), Dabijia Group Acetogel Capsules obtained the drug registration certificate.

16:55 02/02/2026

China Medical (600056.SH) issued an announcement that recently, its wholly-owned subsidiary Tianfang Pharmaceutical Co., Ltd. ("Tianfang Pharmaceutical") received two daptomycin capsules "Drug Registration Certificates" approved and issued by the National Medical Products Administration, with specifications of 150mg (as CHNO) and 110mg (as CHNO).

China Meheco Group (600056.SH) announced that its wholly-owned subsidiary, Tianfang Pharmaceutical Co., Ltd. (referred to as "Tianfang Pharmaceutical"), recently received two dabigatran etexilate capsules "Drug Registration Certificates" issued by the National Medical Products Administration. The specifications are 150mg (calculated as CHNO) and 110mg (calculated as CHNO). Dabigatran etexilate is a direct thrombin inhibitor, mainly used to reduce the risk of stroke and systemic embolism in non-valvular atrial fibrillation, treat deep vein thrombosis and pulmonary embolism, lower the risk of recurrence of deep vein thrombosis and pulmonary embolism, and prevent deep vein thrombosis and pulmonary embolism after hip replacement surgery.

XD INC (02400) spent 1.9227 million Hong Kong dollars on February 2 to repurchase 22,000 shares.

XIAOMI-W (01810) spent HK$209 million on February 2nd to repurchase 6 million shares.

IH RETAIL (01373) spent HK$105,000 on February 2nd to repurchase 150,000 shares.

XD INC (02400) spent 1.9227 million Hong Kong dollars on February 2 to repurchase 22,000 shares.

XIAOMI-W (01810) spent HK$209 million on February 2nd to repurchase 6 million shares.

IH RETAIL (01373) spent HK$105,000 on February 2nd to repurchase 150,000 shares.